MedPath

Acupuncture or ear acupuncture for weight loss in Polycystic Ovary Syndrome

Not Applicable
Conditions
Polycystic Ovary Syndrome
Overweight
Obesity
Metabolic and Endocrine - Metabolic disorders
Alternative and Complementary Medicine - Other alternative and complementary medicine
Reproductive Health and Childbirth - Other reproductive health and childbirth disorders
Registration Number
ACTRN12618000975291
Lead Sponsor
ICM Health Research Institute, Western Sydney University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Female
Target Recruitment
29
Inclusion Criteria

women aged 18-45 years
•physician diagnosis of PCOS according to the 2003 Rotterdam Criteria in previous 5 years
•BMI greater than 25 kg/m2; no other endocrine disorders;
•not pregnant/no pregnancies in preceding 6 weeks and more than 6 weeks postpartum;
•no breastfeeding within the last 6 weeks;
not on the following medications in the 3 months preceding enrolment: metformin or other medications affecting insulin and glucose metabolism, hormonal treatments for PCOS/ART including gonadotrophins and the Oral Contraceptive Pill, pharmaceutical or complementary therapies for weight loss

Exclusion Criteria

•Planning to conceive within the next 3 months
•Needle acupuncture in the previous 3 weeks
•Unable to provide informed consent.
•BMI >40
•anticoagulant use
•pacemaker use
•immunocompromise
•valvular heart disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recruitment rates calculated as : number of women enrolled per month of active recruitment, number of enquiries per month of active recruitment; percentage conversion to enrolment measured as n enrolled/n enquiries and n enrolled/n potentially eligible.[3 months post-intervention commencement];Acceptability assessed by an exit survey designed specifically for the study[3 months post-intervention commencement];Retention rate calculated as number of women remaining in study at 3 months post intervention as a proportion of number of women who enrolled in the study[3 months post-intervention commencement]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath